Evidence map›Paper›PMID 40430443›Full record

ReviewPharmaceuticals (Basel, Switzerland)2025

The Relevance of Pharmacokinetic Biomarkers in Response to Methadone Treatment: A Systematic Review.

Sheila Recarey-Rama, Jesús Gómez-Trigo, Almudena Gil-Rodriguez, Eduardo Dominguez, Inés Sánchez-Martínez, Ángela Riveiro-Recimil, Alba Barral-Raña, Jose de Leon, Ana Rodriguez-Viyuela, Manuel Arrojo and 2 more

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sheila Recarey-RamaGenomic Medicine Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0009-0003-1623-1110
Jesús Gómez-TrigoGenomic Medicine Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Almudena Gil-RodriguezGenomic Medicine Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0002-7637-6915
Eduardo DominguezGenomic Medicine Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0003-3359-5867
Inés Sánchez-MartínezFaculty of Pharmacy, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain.
Ángela Riveiro-RecimilGenetics Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.
Alba Barral-RañaGenomic Medicine Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Jose de LeonMental Health Research Center at Eastern State Hospital, University of Kentucky, Lexington, KY 40511, USA.ORCID 0000-0002-7756-2314
Ana Rodriguez-ViyuelaGenomic Medicine Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Manuel ArrojoPsychiatry Service, University Hospital Complex of Santiago de Compostela, Galician Health System (SERGAS), 15706 Santiago de Compostela, Spain.
Angel CarracedoGenomic Medicine Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.ORCID 0000-0003-1085-8986
Olalla MaroñasGenomic Medicine Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.

Funding

This study was funded by Instituto de Salud Carlos III (ISCIII) and co-funded with European Union funds. PI22/01166
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersgenesmaintenance therapiesmetabolismmethadoneopioid addictionpharmacogenetics

Identifiers

PMID40430443
PMCPMC12115004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.